Literature DB >> 7681356

Angiotensin-(1-7) and nitric oxide synthase in the hypothalamo-neurohypophysial system.

J Calka1, C H Block.   

Abstract

The organization of angiotensin (Ang)-(1-7) immunoreactivity with respect to neurons containing the nitric oxide synthase, nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d), in the hypothalamo-neurohypophysial (HNS) system was examined. The majority of neurons in this system were single labeled with Ang-(1-7) or NADPH-d and were found localized in two separate populations of neurons within the HNS. A small number of double-labeled neurons were observed in the supraoptic (SO) and paraventricular (PV) nuclei. Double-labeled accessory neurosecretory neurons were also found distributed between the SO and PV. Although a well-defined function for nitric oxide in the magnocellular hypothalamic system has not been determined, the codistribution and limited coexistence of Ang-(1-7), a heptapeptide involved in antidiuresis, and NADPH-d in the HNS suggests a potential role for these substances in mechanisms modulating fluid homeostasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681356     DOI: 10.1016/0361-9230(93)90099-w

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  12 in total

Review 1.  Renin-angiotensin system blockers and modulation of radiation-induced brain injury.

Authors:  M E Robbins; W Zhao; M A Garcia-Espinosa; D I Diz
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

2.  Augmented central nitric oxide production inhibits vasopressin release during hemorrhage in acute alcohol-intoxicated rodents.

Authors:  Annie M Whitaker; Jesse K Sulzer; Patricia E Molina
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-17       Impact factor: 3.619

3.  Angiotensin (1-7) contributes to nitric oxide tonic inhibition of vasopressin release during hemorrhagic shock in acute ethanol intoxicated rodents.

Authors:  Annie M Whitaker; Patricia E Molina
Journal:  Life Sci       Date:  2013-08-31       Impact factor: 5.037

Review 4.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

5.  Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure.

Authors:  Hong Zheng; Xuefei Liu; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

Review 6.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

7.  Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.

Authors:  Yumei Feng; Huijing Xia; Yanhui Cai; Carmen M Halabi; Lenice K Becker; Robson A S Santos; Robert C Speth; Curt D Sigmund; Eric Lazartigues
Journal:  Circ Res       Date:  2009-11-19       Impact factor: 17.367

Review 8.  Integrative Physiological Aspects of Brain RAS in Hypertension.

Authors:  Sharon D B de Morais; Julia Shanks; Irving H Zucker
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

9.  Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors.

Authors:  Antonio J Magaldi; Katia R Cesar; Magali de Araújo; Ana C Simões e Silva; Robson A S Santos
Journal:  Pflugers Arch       Date:  2003-10-08       Impact factor: 3.657

10.  ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke.

Authors:  Teng Jiang; Li Gao; Jie Lu; Ying-Dong Zhang
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.